Company Filing History:
Years Active: 2019-2020
Title: Innovator Kris Reedquist: Pioneering Antibody Treatments
Introduction
Kris Reedquist is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of medical treatments, particularly through his innovative work with antibodies. With a total of 2 patents, Reedquist is recognized for his advancements in treating various inflammatory conditions.
Latest Patents
Reedquist's latest patents focus on methods of treating conditions with antibodies that bind to the colony stimulating factor 1 receptor (CSF1R). These methods include techniques for reducing cytokine levels and treating inflammatory conditions, such as rheumatoid arthritis. His work aims to provide effective solutions for patients suffering from these debilitating diseases.
Career Highlights
Kris Reedquist is currently associated with Five Prime Therapeutics, Inc., where he continues to develop groundbreaking therapies. His expertise in antibody treatments has positioned him as a key figure in the biotechnology sector. His contributions are vital in advancing the understanding and treatment of inflammatory conditions.
Collaborations
Reedquist collaborates with talented professionals in his field, including Brian Wong and Emma Masteller. These partnerships enhance the innovative potential of his research and development efforts.
Conclusion
Kris Reedquist's work exemplifies the impact of innovation in medical treatments. His patents and ongoing research contribute significantly to the advancement of therapies for inflammatory conditions.